Trial record 13 of 456 for:    Open Studies | "Stomach Diseases"

The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer

This study is currently recruiting participants.
Verified November 2013 by Showa Inan General Hospital
Sponsor:
Information provided by (Responsible Party):
Akira Horiuchi, Showa Inan General Hospital
ClinicalTrials.gov Identifier:
NCT00596401
First received: January 8, 2008
Last updated: November 15, 2013
Last verified: November 2013
  Purpose

Recently, the preventive effect of Helicobacter pylori (Hp) eradication treatment on the incidence of gastric cancer has been reported. By Hp eradication treatment being performed for Hp-infected people in Iijima town, we will evaluate whether the incidence of gastric cancer and/or the medical care cost can be reduced as compared with those in the previous years.


Condition
Helicobacter Pylori
Eradication
Gastric Cancer
Medical Care Cost

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer and the Medical Care Cost in Iijima Town

Resource links provided by NLM:


Further study details as provided by Showa Inan General Hospital:

Primary Outcome Measures:
  • the annual incidence of gastric cancer in Iijima town [ Time Frame: 10 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The annual medical care cost in Iijima town [ Time Frame: 10 years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

serum


Estimated Enrollment: 3000
Study Start Date: September 2007
Estimated Study Completion Date: August 2017
Estimated Primary Completion Date: August 2017 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
HP eradication group
2
No eradication group
3
No Hp group

  Eligibility

Ages Eligible for Study:   19 Years to 69 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

People who live in Iijima town

Criteria

Inclusion Criteria:

  • People who live in Iijima town at their age of 19 to 69 years
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00596401

Contacts
Contact: Akira Horiuchi, M.D. 81265822121 ext 3012 horiuchi.akira@sihp.jp

Locations
Japan
Showa Inan General hospital Recruiting
Komagane, Nagano, Japan, 399-4191
Contact: Akira Horiuchi, M.D.    81265822121 ext 3012    horiuchi.akira@sihp.jp   
Principal Investigator: Akira Horiuchi, M.D.         
Sponsors and Collaborators
Showa Inan General Hospital
Investigators
Study Director: Akira Horiuchi, M.D. Showa Inan General Hospital
  More Information

No publications provided

Responsible Party: Akira Horiuchi, Digestive Disease Center, Showa Inan General Hospital
ClinicalTrials.gov Identifier: NCT00596401     History of Changes
Other Study ID Numbers: sihp20076
Study First Received: January 8, 2008
Last Updated: November 15, 2013
Health Authority: Japan: Ministry of Health, Labor and Welfare

Additional relevant MeSH terms:
Stomach Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Stomach Diseases

ClinicalTrials.gov processed this record on April 15, 2014